News Entero Therapeutics, Inc.

Equities

ENTO

US33749P4081

Market Closed - Nasdaq Other stock markets 02:00:00 19/06/2024 am IST			5-day change	1st Jan Change
1.94 ^USD	-6.73%		-6.28%	-53.81%

20/05	Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index	CI
17/05	First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Entero Therapeutics : Corporate Presentation (Entero Therapeutics June 2024 Corporate Presentation 2024.6.12 ADA Compliant)	12/06	PU
Entero Therapeutics : Corporate Fact Sheet (Entero Therapeutics Q224 Factsheet 2024.6.7 ADA Compliant 1)	07/06	PU
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention	22/05	AQ
Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index	20/05	CI
First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc	17/05	CI
First Wave BioPharma Changes Name to Entero Therapeutics	16/05	AQ
First Wave BioPharma, Inc.(NasdaqGM:ENTO) dropped from NASDAQ Composite Index	16/05	CI
First Wave BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market	10/05	AQ
First Wave BioPharma, Inc. announced a financing transaction	10/05	CI
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month	09/05	AQ
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	24/04	AQ
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	17/04	AQ
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	15/04	AQ
First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03	CI
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	18/03	AQ
Sector Update: Health Care Stocks Retreating Late Afternoon	15/03	MT
Sector Update: Health Care	15/03	MT
First Wave BioPharma Shares Fall After Acquiring ImmunogenX	14/03	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Inflation Data	14/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Entero Therapeutics, Inc.

Equities

ENTO

US33749P4081

Summary

Filters